Viberzi Alternatives Compared
Viberzi | Xifaxan | Alosetron |
|
---|
Viberzi (eluxadoline) | Xifaxan (rifaximin) | Alosetron |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Irritable Bowel Syndrome with Diarrhea, Diarrhea, Irritable Bowel Syndrome. Viberzi may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Hepatic Encephalopathy, Irritable Bowel Syndrome with Diarrhea, Irritable Bowel Syndrome, Traveler's Diarrhea, Diarrhea. Xifaxan may also be used for purposes not listed in this... View more |
Prescription only
Prescribed for Irritable Bowel Syndrome with Diarrhea, Diarrhea, Diarrhea - Chronic, Irritable Bowel Syndrome. alosetron may also be used for purposes not listed in this medication guide. |
Related suggestions Irritable Bowel Syndrome
Irritable Bowel Syndrome with Diarrhea
|
|||||||||||||||||||||||
More about Viberzi (eluxadoline) | More about Xifaxan (rifaximin) | More about Alosetron | ||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Viberzi has an average rating of 6.7 out of 10 from a total of 216 ratings on Drugs.com. 57% of reviewers reported a positive effect, while 26% reported a negative effect. |
Xifaxan has an average rating of 6.5 out of 10 from a total of 94 ratings on Drugs.com. 59% of reviewers reported a positive effect, while 34% reported a negative effect. |
Alosetron has an average rating of 9.0 out of 10 from a total of 31 ratings on Drugs.com. 93% of reviewers reported a positive effect, while 3% reported a negative effect. |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Side Effects | ||||||||||||||||||||||||||
See also: Viberzi side effects in more detail. |
See also: Xifaxan side effects in more detail. |
See also: alosetron side effects in more detail. |
||||||||||||||||||||||||
Generic Availability | ||||||||||||||||||||||||||
Lower cost generic |
||||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Viberzi prices |
View all Xifaxan prices |
View all alosetron prices |
||||||||||||||||||||||||
Dosage Forms Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
N/A |
N/A |
Lotronex | ||||||||||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
6 hours |
10.19 hours |
1.5 hours |
||||||||||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
Some potential for abuse
Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 212 drugs are known to interact with Viberzi:
|
A total of 71 drugs are known to interact with Xifaxan:
|
A total of 89 drugs are known to interact with alosetron:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
May 27, 2015 |
May 25, 2004 |
February 09, 2000 |
||||||||||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.